Method to detect Dirofilaria immitis infection

• US 6,391,569 B1
• Filed: 09/18/1996
• Issued: 05/21/2002
• Est. Priority Date: 09/18/1996
• Status: Expired due to Term

• Current Assignee: Heska Corporation (Mars Incorporated)
• Original Assignee: Heska Corporation (Mars Incorporated)
• Inventors: Mondesire, Roy R., Porter, James P., Frank, Glenn R., Wisnewski, Nancy, Grieve, Robert B.
• Primary Examiner(s): MINNIFIELD, NITA M
• Application Number:
  US08/715,628
• Time in Patent Office: 2,071 Days
• Field of Search: 435/7.22, 435/7.92, 435/7.93, 435/7.94, 435/7.95, 435/7.1, 435/69.1, 435/342, 435/598, 530/350, 530/387.1, 530/388.6, 530/403, 424/191.1, 424/192.1, 424/269.1, 424/151.1
• US Class Current: 435/7.22
• CPC Class Codes: C07K 14/4354 from nematodes
• CPC Class Codes: G01N 2333/4353 from nematodes
• CPC Class Codes: G01N 33/569 for microorganisms, e.g. protozoa, bacteria, viruses

Abstract

The present invention includes a method to detect D. immitis infection in a host animal using a D. immitis Di33 protein to detect anti-D. immitis Di33 antibodies in a bodily fluid of the animal. Also included is a method to detect D. immitis infection in a host animal using a D. immitis anti-Di33 protein to detect Di33 proteins in a bodily fluid of the animal. The present invention also relates to D. immitis detection kits that include either a Di33 protein or an anti-Di33 antibody; such kits also include a composition to detect an immunocomplex between the anti-Di33 antibody and D. immitis Di33 protein. The present invention also includes Di33 proteins, nucleic acid molecules encoding such proteins, as well as recombinant molecules and recombinant cells comprising such nucleic acid molecules, and anti-Di33 antibodies. Also included are methods to produce such proteins, nucleic acid molecules and antibodies.

Claims

1. A method to detect D. immitis infection in a non-adapted host comprising:

(a) contacting a bodily fluid collected from said host with a formulation comprising a recombinant D. immitis Di33 protein under conditions sufficient to form an immunocomplex between said recombinant D. immitis Di33 protein and anti-Di33 antibodies;

(b) measuring immunocomplex formation between said recombinant D. immitis Di33 protein and anti-Di33 antibodies, if any, in said fluid, wherein the presence of said immunocomplex indicates that said host is or has recently been infected with D. immitis, wherein said recombinant D. imminitis Di33 protein is not cross-reactive with scrum from a host infected with an organism selected from the group consisting of Taenia taeniaeformis, Toxocara cati, and Ancylostoma tubaeforme at 10 weeks post-infection, and wherein said method detects D. immitis infection resulting in the maturation of a single adult heartworm.

2. The method of claim 1, wherein said method detects D. immitis infection in said host prior to maturation of said D. immitis into an adult heartworm.

3. The method of claim 1, wherein said method detects D. immitis infection in said host within at least ten weeks post infection of said host with D. immitis.

4. The method of claim 1, wherein said method detects D. immitis infection in a non-adapted host harboring adult heartworms.

5. The method of claim 1, wherein said method detects D. immitis infection resulting in the maturation of a single adult male heartworm.

6. The method of claim 1, wherein said method detects D. immitis infection resulting in the maturation of a single adult female heartworm.

7. The method of claim 1, wherein said host is selected from the group consisting of a cat and a ferret.

8. The method of claim 1, wherein said immunocomplex is measured by contacting said recombinant D. immitis Di33 protein-contacted bodily fluid with a composition that selectively binds to an antibody selected from the group consisting of an IgG anibody, an IgE antibody, an IgM antibody, and an IgA antibody.

9. The method of claim 8, wherein said composition is conjugated to a detectable marker.

10. The method of claim 8, wherein said composition is immobilized on a substrate.

11. The method of claim 1, wherein said recombinant D. immitis Di33 protein is immobilized on a substrate.

12. The method of claim 1, wherein said immunocomplex forms in solution.

13. The method of claim 1, wherein said step of measuring comprises an assay selected from the group consisting of an enzyme-linked immunoassay, a radioimmunoassay, a fluorescence immunoassay, a lateral flow assay, an agglutination assay, a particulate-based assay, an immonoprecipitation assay, and a immunoblotting assay.

14. The method of claim 1, wherein said recombinant D. immitis Di33 protein is conjugated to a detectable marker.

15. A method to detect D. immitis infection in a non-adapted host animal, said method comprising:

(a) contacting a bodily fluid collected from said animal with a formulation comprising a recombinant D. immitis Di33 protein under conditions sufficient to form an immunocomplex between said recombinant D. immitis Di33 protein and anti-Di33 IgE antibodies; and

(b) measuring immunocomplex formation between said recombinant D. immitis Di33 protein and anti-Di33 IgE antibodies, if any, in said fluid, wherein the presence of said immunocomplex indicates that said animal is or has recently been infected with D. immitis, wherein said recombinant D. immitis Di33 protein is not cross-reactive with scrum from a host infected with an organism selected from the group consisting of Taenia taeniaeformis, Toxocara cati, and Ancylostoma tubaeforme at 10 weeks post-infection and wherein said method detects D. immitis infection resulting in the maturation of a single adult heartworm.

16. The method of claim 15, wherein said animal is selected from the group consisting of cats and ferrets.

17. The method of claim 15, wherein said method detects D. immitis infection in said animal within at least ten weeks post infection of said animal with D. immitis.